Update results of paclitaxel and cisplatin in combination with anlotinib as first-line regimen for patients with advanced ESCC: a multicenter, single-arm, open-label phase II clinical trial.
Anlotinib;Cisplatin;Paclitaxel
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Update results of paclitaxel and cisplatin in combination with anlotinib as first-line regimen for patients with advanced ESCC: a multicenter, single-arm, open-label phase II clinical trial. ### Output: Anlotinib;Cisplatin;Paclitaxel